---
title: "Pre-market hot trades in US stocks: MV Oil Trust up 6.74% in pre-market; AXT down 4.06% in pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291917548.md"
description: "MV Oil Trust rose 6.74% in pre-market; AXT Company fell 4.06% in pre-market; Crinetics Pharmaceuticals rose 99.26% in pre-market; Trident Digital Tech rose 71.98% in pre-market; Bluejay Diagnostics rose 29.31% in pre-market"
datetime: "2026-07-07T10:37:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291917548.md)
  - [en](https://longbridge.com/en/news/291917548.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291917548.md)
---

# Pre-market hot trades in US stocks: MV Oil Trust up 6.74% in pre-market; AXT down 4.06% in pre-market

**Popular Pre-Market Trades in US Stocks**

MV Oil Trust, up 6.74% in pre-market trading, has no significant news recently. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

AXT Company, down 4.06% in pre-market trading. Based on recent key news:

1.  On July 5, AXT signed a three-year supply contract with Coherent, expecting rapid enhancement of momentum in the AI optical communication business. This contract will drive demand for indium phosphide, with an expected performance explosion in the second half of the year. Source: Zhitong Finance
    
2.  On July 6, a report from Nomura Securities pointed out that the warming of AI infrastructure construction has led to a rise in indium phosphide material prices, making AXT one of the main beneficiaries. Material prices are expected to continue rising. Source: Wall Street Insight
    
3.  On July 5, the epitaxial factory announced that it has obtained the source of indium phosphide substrate materials from AXT, expecting enhanced shipping momentum in Q3 and an optimistic outlook for the year. Source: Zhitong Finance AI demand drives growth in the optical communication industry.
    

**Top Gainers in Pre-Market US Stocks**

Crinetics Pharmaceuticals, up 99.26% in pre-market trading. Based on recent key news:

1.  On July 7, Fortress Biotech announced it would acquire Crinetics Pharmaceuticals for $85 per share in cash, with a total value of approximately $10 billion. This news triggered a positive response from investors, leading to a pre-market surge of 99.26% in Crinetics' stock price.
    
2.  On July 7, Fortress Biotech stated that this acquisition would expand its business in the endocrinology field and is expected to have a positive impact on adjusted operating profit by 2029. This expectation further propelled the rise in Crinetics' stock price.
    
3.  On July 7, analysts changed their ratings on Crinetics, with Oppenheimer analysts downgrading their rating from "Outperform" to "Perform," and Cantor Fitzgerald analysts also downgrading their rating from "Buy" to "Neutral." Nevertheless, analysts still believe that Crinetics has a strong biotechnology pipeline, expecting significant sales growth for its core products in the coming years. The biopharmaceutical industry has performed strongly recently, with noticeable capital inflows.
    

Trident Digital Tech, up 71.98% in pre-market trading. Based on recent key news:

1.  On July 6, Trident Digital Tech announced the termination of its ADS program and the transition to direct Nasdaq common stock trading. This move aims to simplify the shareholder structure and improve trading liquidity, leading to a significant rise in stock price.
    
2.  On July 6, the company implemented a 240-for-1 Cayman stock consolidation, further optimizing its capital structure, enhancing market confidence, and driving the stock price up
    
3.  Recently, there are no other important news. Market liquidity has increased, and risks need to be monitored.
    

Bluejay Diagnostics, pre-market up 29.31%, has no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [MVO.US](https://longbridge.com/en/quote/MVO.US.md)
- [AXTI.US](https://longbridge.com/en/quote/AXTI.US.md)
- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [TDTH.US](https://longbridge.com/en/quote/TDTH.US.md)
- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)

## Related News & Research

- [Here's How Much $1000 Invested In AXT 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/294852180.md)
- [Veeco wins LUMINA+ MOCVD order to manufacture indium phosphide lasers for datacom market](https://longbridge.com/en/news/295014070.md)
- [Kinder Morgan Just Locked In a $5 Billion Pipeline Deal. Here's What It Means for KMI's Dividend.](https://longbridge.com/en/news/295670754.md)
- [Atkore Pres. Safety & Infrastructure Mark F. Lamps sells 300 shares for $28,125](https://longbridge.com/en/news/295452306.md)
- [Femasys wins new US, international patents covering FemBloc blended polymer component](https://longbridge.com/en/news/295683564.md)